Status:
UNKNOWN
Surfactant for Neonatal Respiratory Distress Syndrome at High Altitude Areas:a Prospective Cohort Study
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Collaborating Sponsors:
the first people hospital of Tibet autonomous region
the second people hospital of Lasa
Conditions:
Surfactant
Eligibility:
All Genders
10-1 years
Brief Summary
The traditional concept believes that the etiology of neonatal respiratory distress syndrome (RDS) is immature development of lung,especially the surfactant synthesis system,and RDS is still one of th...
Detailed Description
in order to explore feasibility and efficacy for PS treatment of newborn RDS in high-altitude area ,and its efficacy at different altitudes, the investigators conduct a multi-center retrospective stud...
Eligibility Criteria
Inclusion
- the preterm infants less than 37 weeks were included in the study;diagnosed with NRDS
Exclusion
- parents' rejecting to join;major congenital abnormalities
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03479450
Start Date
March 1 2020
End Date
December 1 2022
Last Update
February 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatrics, Daping Hospital, Third Military Medical University
Chongqing, Chongqing Municipality, China, 400042